An observational study in Peripheral Neurogenic Pain, sponsored by Fisiopoint Parma Physiotherapy. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-03.
Sponsored by Fisiopoint Parma Physiotherapy · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 213 studies in Pain with a site in Italy — 35 open to participants now, 41 under way, 1 of them phase 3. Pain · Italy.
Among the 213 studies in Pain with a site in Italy, this one is the 13th largest by planned enrollment of the 56 observational ones that give a count, is one of 8 that started in 2026, is one of 57 observational ones, reaches primary completion later than 39 of the 40 other live ones, and was the 208th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →35 of the 213 studies in Pain with a site in Italy are open now. Recruiting first, the newest first:
Universita di Verona · Sites in Italy
Ages 18+
Ospedale degli Infermi di Biella · Sites in Italy
Ages 25–60 · Women only
Catholic University of the Sacred Heart · Sites in Italy
Ages 18–79 · Healthy volunteers
Istituto Oncologico Veneto IRCCS · Sites in Italy
Ages 18–99
Università degli Studi del Piemonte Orientale Amedeo Avogadro · Sites in Italy
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
213 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 12 · Phase 3 30 · Phase 4 13
First in 2003; this study’s year is marked. 8 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 280 is above the median of 100 across 1,253 observational studies indexed under Pain.
Median enrollment 80 across the 156 interventional studies, 142 across the 56 observational. Of the 139 that completed or were terminated, 19 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
37 of 213 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Fisiopoint Parma Physiotherapy as lead sponsor.
Fisiopoint Parma Physiotherapy has 1 study filed under Pain — fewer than ten, so there is no comparison to draw.
11 of the studies in Pain with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07646795Martina StefaniniAlveolar Ridge Reconstruction in Post-extraction Sites Using a Magnesium Resorbable Membrane. An Explorative Study | 2026-11-27 |
| NCT05666921Meyer Children's Hospital IRCCSAlexithymia and Attachment Style in Patients With Somatic Symptoms | 2026-12 |
| NCT07338292Istituto Oncologico Veneto IRCCSVIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures | 2026-12-31 |
| NCT07123805Fondazione IRCCS Policlinico San Matteo di PaviaACU_Knee: Role of Acupuncture in Knee Prosthetic Surgery | 2026-12-31 |
| NCT06409832University of FlorenceRimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment | 2027-01-01 |
Add all 11 to your calendar (.ics) → With an account.
Among the 213 studies in Pain with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This observational diagnostic accuracy study will evaluate the ability of the Slump Lateral Bending Test to identify patients with suspected peripheral neurogenic pain or neural mechanosensitivity. Adult participants will be assessed using clinical examination procedures, including the Slump Lateral Bending Test and other neurological and neurodynamic findings. Thes study aims to determine whether this test may help clinicians recognize patients in whom peripheral nerve involvement contributes to symptoms. The results may support clinical reasoning in physiotherapy and improve the assessment o patients with suspected neurogenic pain.
Adult patients with suspected peripheral neurogenic pain or neural mechanosensitivity who are referred for physiotherapy assessment will be considered for inclusion. Participants may present with symptoms such as pain, paresthesia, dysesthesia, or movement-related symptoms potentially associated with peripheral nerve involvement. Eligible patients will undergo a standardized clinical assessment including neurological and neurodynamic examination procedures, including the Slump Lateral Bending Test.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Sensitivity and Specificity of the SLBT for MRI-Confirmed Lumbar Nerve Root Contact or Compression
Sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios, and overall diagnostic accuracy of the Slump Lateral Bending Test will be calculated using lumbar MRI findings classified as nerve root contact or compression as the reference standard.
Time frame: At baseline
Started Jun 2026 (actual). Primary completion is estimated for Jun 2029, 35 months after the start.
Of 505 non-industry observational studies under Pain, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's planned 35 months is above that.
Counting every sponsor, half of 520 studies reached it within 18 months; a quarter within 8 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.